Elite Pharmaceuticals Files 8-K
Ticker: ELTP · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1053369
| Field | Detail |
|---|---|
| Company | Elite Pharmaceuticals INC /NV/ (ELTP) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, disclosure
TL;DR
Elite Pharma filed an 8-K on 6/23/25, mostly procedural stuff with exhibits.
AI Summary
Elite Pharmaceuticals, Inc. filed an 8-K on June 23, 2025, reporting on events that occurred on the same date. The filing primarily concerns financial statements and exhibits, as well as a Regulation FD Disclosure. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Elite Pharmaceuticals is providing updated information to the SEC, which could include financial details or disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- ELITE PHARMACEUTICALS, INC. (company) — Registrant
- ELITE PHARMACEUTICALS INC /NV/ (company) — Registrant (Exact name)
- Nevada (jurisdiction) — State of incorporation
- 001-15697 (company) — Commission File Number
- 22-3542636 (company) — IRS Employer Identification No.
- 165 Ludlow Avenue, Northvale, New Jersey 07647 (address) — Principal executive offices
- 2017502646 (phone_number) — Registrant's telephone number
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The filing indicates 'Financial Statements and Exhibits' are included, but the specific details are not provided in this excerpt.
What is the nature of the Regulation FD Disclosure mentioned in the filing?
The filing states a 'Regulation FD Disclosure' is part of the report, but the content of this disclosure is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated June 23, 2025.
What is Elite Pharmaceuticals, Inc.'s state of incorporation?
Elite Pharmaceuticals, Inc. is incorporated in Nevada.
What is the principal executive office address for Elite Pharmaceuticals, Inc.?
The principal executive office is located at 165 Ludlow Avenue, Northvale, New Jersey 07647.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding ELITE PHARMACEUTICALS INC /NV/ (ELTP).